Dorzolamide hydrochloride and timolol maleate and Memory aids for Women aged 60+ (a phase IV clinical study of FDA data)

Summary:

Memory aids is found for women aged 60+ who take Dorzolamide hydrochloride and timolol maleate (dorzolamide hydrochloride; timolol maleate). This study is created by eHealthMe based on reports of 365 women aged 60+ from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:

Time on Dorzolamide hydrochloride and timolol maleate when people have Memory aids
Top conditions
Top co-used drugs
Top other side effects

On Feb, 16, 2026

365 women aged 60+ reported to have side effects when taking Dorzolamide hydrochloride and timolol maleate.
Among them, 19 people (5.21%) have Memory aids

What is Dorzolamide hydrochloride and timolol maleate?

Dorzolamide hydrochloride and timolol maleate has active ingredients of dorzolamide hydrochloride; timolol maleate. eHealthMe is studying from 771 Dorzolamide hydrochloride and timolol maleate users. Check the latest studies of Dorzolamide hydrochloride and timolol maleate.

What is Memory aids?

Memory aids is found to be associated with 3,923 drugs and 4,590 conditions by eHealthMe. Check the latest studies of Memory aids.

Number of reports submitted per year:

Could Dorzolamide hydrochloride and timolol maleate cause Memory aids in women aged 60+?

Severity of Memory aids

n/a

How people recovered from Memory aids

n/a

Top conditions involved for these people *:

You may use this to check any potential undetected conditions.

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 16 people, 84.21%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 11 people, 57.89%
Pneumonia: 7 people, 36.84%
Limb Discomfort (discomfort in leg): 7 people, 36.84%
Temporal Arteritis (inflammation and damage to blood vessels that supply the head area): 1 person, 5.26%
Pain: 1 person, 5.26%
High Blood Pressure: 1 person, 5.26%
High Blood Cholesterol: 1 person, 5.26%
Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 5.26%
Fever: 1 person, 5.26%

Top co-used drugs for these people *:

You may use this to check any potential interacting drugs.

Top other side effects for these people *:

You may use this to check any potential undetected side effects.

Drug Intolerance (drug sensitivity): 18 people, 94.74%
High Blood Pressure: 18 people, 94.74%
Drug Ineffective: 17 people, 89.47%
Glaucoma (increased fluid pressure in the eye with vision loss): 17 people, 89.47%
Mobility Decreased (ability to move is reduced): 17 people, 89.47%
Pneumonia: 17 people, 89.47%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 17 people, 89.47%
Hypersensitivity: 16 people, 84.21%
Leukopenia (less number of white blood cells in blood): 16 people, 84.21%
Drug Hypersensitivity: 16 people, 84.21%

* Approximation only. Some reports may have incomplete information.

Do you take Dorzolamide hydrochloride and timolol maleate and have Memory aids?

- Check whether Memory aids is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies:

Dorzolamide hydrochloride and timolol maleate and Memory aids

How the study uses the data?

The study is based on (applicable) gender, age, dorzolamide hydrochloride; timolol maleate (the active ingredients of Dorzolamide hydrochloride and timolol maleate) and Dorzolamide hydrochloride and timolol maleate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.